Style | Citing Format |
---|---|
MLA | Eizadimood N, et al.. "Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs." Journal of Isfahan Medical School, vol. 40, no. 692, 2022, pp. 857-864. |
APA | Eizadimood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R (2022). Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs. Journal of Isfahan Medical School, 40(692), 857-864. |
Chicago | Eizadimood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. "Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs." Journal of Isfahan Medical School 40, no. 692 (2022): 857-864. |
Harvard | Eizadimood N et al. (2022) 'Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs', Journal of Isfahan Medical School, 40(692), pp. 857-864. |
Vancouver | Eizadimood N, Khademi N, Haddad S, Aliabadi MG, Golshiri P, Meamar R. Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs. Journal of Isfahan Medical School. 2022;40(692):857-864. |
BibTex | @article{ author = {Eizadimood N and Khademi N and Haddad S and Aliabadi MG and Golshiri P and Meamar R}, title = {Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs}, journal = {Journal of Isfahan Medical School}, volume = {40}, number = {692}, pages = {857-864}, year = {2022} } |
RIS | TY - JOUR AU - Eizadimood N AU - Khademi N AU - Haddad S AU - Aliabadi MG AU - Golshiri P AU - Meamar R TI - Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned With Selective Serotonin Reuptake Inhibitor Drugs JO - Journal of Isfahan Medical School VL - 40 IS - 692 SP - 857 EP - 864 PY - 2022 ER - |